EDGAR Filing Documents for 0001193125-22-211258

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-22-211258

Filing Date

2022-08-03

Accepted

2022-08-03 16:05:17

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d373513d424b5.htm	424B5	464103
2	GRAPHIC	g373513g40j26.jpg	GRAPHIC	60432
3	GRAPHIC	g373513g53g03.jpg	GRAPHIC	104603
4	GRAPHIC	g373513g61f43.jpg	GRAPHIC	81922
	Complete submission text file	0001193125-22-211258.txt		805714

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121

Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100

Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-258804 | Film No.: 221132500
SIC: 2836 Biological Products, (No Diagnostic Substances)